01—Abstract
Summary
Summary of the 8-K/A filed April 9, 1997. Cited figures are marked; the original filing is the authoritative source.
This Form 8-K/A (Amendment No. 1) from The Procter & Gamble Company (NYSE: PG) reports that on April 8, 1997, P&G entered into an Agreement and Plan of Merger among the Company, C.R.
MacIntosh, Inc., and Tambrands Inc. The filing discloses the transaction under Item 5 (Other Events) and identifies Tambrands Inc. as the merger counterparty, indicating P&G's intent to acquire Tambrands, the maker of the Tampax brand of feminine care products. This amendment was filed solely to correct an error in Exhibit 1 to P&G's original Form 8-K. It does not add new financial terms, deal consideration, or valuation details, so investors should consult the original 8-K, the merger agreement itself, and any subsequent proxy or tender offer materials for price, structure, financing, and timing.
For investors, the key takeaway is that P&G has agreed to a significant acquisition in the feminine care category, expanding its personal care portfolio. The filing itself is administrative in nature, and the economic impact can only be fully assessed from the underlying merger agreement and related disclosures.
02—Key points
Key Highlights
- P&G entered into an Agreement and Plan of Merger on April 8, 1997 with C.R. MacIntosh, Inc. and Tambrands Inc.
- The transaction was disclosed under Item 5 (Other Events) of Form 8-K/A (Amendment No. 1).
- Tambrands Inc. is the target, a leading maker of feminine care products including the Tampax brand.
- This amendment was filed solely to correct an error in Exhibit 1 of the original Form 8-K.
- The amendment contains no new deal terms such as purchase price, consideration, or financing details.
- The acquisition would expand P&G's personal care and feminine care business lines.
- Investors should review the merger agreement and original 8-K for valuation, structure, and timing.
03—Questions
Frequently Asked Questions
What transaction does this filing describe?
P&G entered into an Agreement and Plan of Merger on April 8, 1997 among P&G, C.R. MacIntosh, Inc., and Tambrands Inc. The merger agreement is the basis for P&G's acquisition of Tambrands.
Why was this 8-K/A filed?
The amendment was filed solely to correct an error in Exhibit 1 to P&G's original Form 8-K. It does not change the substance of the merger disclosure.
Does this filing disclose the purchase price?
No. This amendment does not provide purchase price, per-share consideration, or financing terms. Those details would be found in the merger agreement and the original 8-K exhibits.
Who is Tambrands Inc.?
Tambrands Inc. is a manufacturer of feminine care products, best known for the Tampax brand. Its acquisition would strengthen P&G's position in feminine care.
What should investors monitor next?
Investors should watch for shareholder approval materials, regulatory review filings, the expected closing timeline, and any financing or integration disclosures in subsequent SEC filings.
04—Continue